Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹36,595 Cr
verified against source
Revenue YoY
14%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Bajaj Finserv reported a steady Q4 FY25 with consolidated total income up 14% YoY to INR 36,596 crore and PAT up 14% to INR 2,417 crore. The general insurance arm BAGIC saw GWP decline 13% due to accounting changes and volatile crop/government health business, but core retail and commercial lines grew 8-12%, outpacing the industry. Life insurance arm BALIC delivered a strong VNB margin expansion to 22.1% (up ~400bps YoY) driven by product mix shift and cost actions, though PAT fell 61% on lower realized gains. Bajaj Finance continued robust performance with AUM growth of 26% and stable asset quality. Management expressed cautious optimism for H2 FY26, focusing on profitable growth and cost efficiencies. Key risks include regulatory changes, competitive pressure in insurance, and potential market volatility impacting investment gains.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects VNB margin expansion to accelerate, with benefits from cost actions and product mix fully playing out by FY27, but visible from H2 FY26.
- After a muted H1 due to high base and agency channel reset, growth is expected to recover in the second half of FY26.
- Management aims to maintain profitable growth, prioritizing underwriting performance over market share in tender-driven businesses.
- Bajaj Finserv Health and Bajaj Markets are expected to increase transaction volumes and achieve greater scale, with health targeting international expansion.
Risks flagged
- The 1/n regulation for long-term products distorted GWP and combined ratio comparability, and further regulatory shifts could affect reported metrics.
- BALIC's largest bancassurance partner (Axis Bank) contributes 22% of business; the partner's acquisition of a competing insurer could pressure margins or market share.
- Lower realized gains in Q4 due to market conditions dragged PAT for both insurance subsidiaries; continued volatility could affect profitability.
- Aggressive pricing in crop and government health segments led BAGIC to reduce participation, risking market share loss in these lines.
Key quotes
- We are using this opportunity on Team AI and BFL in looking at our OpEx cost in Band-Aid and the margin profiles, restructuring the business on different charges.
- We have also taken significant calls on cost structures, looking at more productive investments, removing wastage, inefficiency, and some places significant cost cuts. This is helping us leverage to an extent you saw that operating leverage show up in Q4.
- If the CBR rule changes, if the fact gets more difficult, we have enough to be able to retain also, and we have enough underwriting competence, which you demonstrated for several years, to write good risk.
Research modules